table of content
1 Study Coverage
1.1 Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Introduction
1.2 Global Transmucosal Drug Delivery Outlook 2017 VS 2022 VS 2028
1.2.1 Global Transmucosal Drug Delivery Market Size for the Year 2017-2028
1.2.2 Global Transmucosal Drug Delivery Market Size for the Year 2017-2028
1.3 Transmucosal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Transmucosal Drug Delivery in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Transmucosal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Transmucosal Drug Delivery Market Dynamics
1.4.1 Transmucosal Drug Delivery Industry Trends
1.4.2 Transmucosal Drug Delivery Market Drivers
1.4.3 Transmucosal Drug Delivery Market Challenges
1.4.4 Transmucosal Drug Delivery Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Transmucosal Drug Delivery by Type
2.1 Transmucosal Drug Delivery Market Segment by Type
2.1.1 Passive Transdermal Drug Delivery
2.1.2 Active Transdermal Drug Delivery
2.2 Global Transmucosal Drug Delivery Market Size by Type (2017, 2022 & 2028)
2.3 Global Transmucosal Drug Delivery Market Size by Type (2017-2028)
2.4 United States Transmucosal Drug Delivery Market Size by Type (2017, 2022 & 2028)
2.5 United States Transmucosal Drug Delivery Market Size by Type (2017-2028)
3 Transmucosal Drug Delivery by Application
3.1 Transmucosal Drug Delivery Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Transmucosal Drug Delivery Market Size by Application (2017, 2022 & 2028)
3.3 Global Transmucosal Drug Delivery Market Size by Application (2017-2028)
3.4 United States Transmucosal Drug Delivery Market Size by Application (2017, 2022 & 2028)
3.5 United States Transmucosal Drug Delivery Market Size by Application (2017-2028)
4 Global Transmucosal Drug Delivery Competitor Landscape by Company
4.1 Global Transmucosal Drug Delivery Market Size by Company
4.1.1 Top Global Transmucosal Drug Delivery Companies Ranked by Revenue (2021)
4.1.2 Global Transmucosal Drug Delivery Revenue by Player (2017-2022)
4.2 Global Transmucosal Drug Delivery Concentration Ratio (CR)
4.2.1 Transmucosal Drug Delivery Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Transmucosal Drug Delivery in 2021
4.2.3 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Transmucosal Drug Delivery Headquarters, Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Type
4.3.1 Global Transmucosal Drug Delivery Headquarters and Area Served
4.3.2 Global Transmucosal Drug Delivery Companies Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Transmucosal Drug Delivery Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Transmucosal Drug Delivery Market Size by Company
4.5.1 Top Transmucosal Drug Delivery Players in United States, Ranked by Revenue (2021)
4.5.2 United States Transmucosal Drug Delivery Revenue by Players (2020, 2021 & 2022)
5 Global Transmucosal Drug Delivery Market Size by Region
5.1 Global Transmucosal Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Transmucosal Drug Delivery Market Size by Region (2017-2028)
5.2.1 Global Transmucosal Drug Delivery Market Size by Region: 2017-2022
5.2.2 Global Transmucosal Drug Delivery Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.1.2 North America Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Transmucosal Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.3.2 Europe Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.4.2 Latin America Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 3M Pharmaceuticals
7.1.1 3M Pharmaceuticals Company Details
7.1.2 3M Pharmaceuticals Business Overview
7.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
7.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.1.5 3M Pharmaceuticals Recent Development
7.2 Acrux Limited
7.2.1 Acrux Limited Company Details
7.2.2 Acrux Limited Business Overview
7.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
7.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.2.5 Acrux Limited Recent Development
7.3 ALZA Corporation
7.3.1 ALZA Corporation Company Details
7.3.2 ALZA Corporation Business Overview
7.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
7.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.3.5 ALZA Corporation Recent Development
7.4 Antares Pharma, Inc.
7.4.1 Antares Pharma, Inc. Company Details
7.4.2 Antares Pharma, Inc. Business Overview
7.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
7.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.4.5 Antares Pharma, Inc. Recent Development
7.5 Apricus BioSciences, Inc
7.5.1 Apricus BioSciences, Inc Company Details
7.5.2 Apricus BioSciences, Inc Business Overview
7.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
7.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.5.5 Apricus BioSciences, Inc Recent Development
7.6 Aveva Drug Delivery Systems
7.6.1 Aveva Drug Delivery Systems Company Details
7.6.2 Aveva Drug Delivery Systems Business Overview
7.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
7.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.6.5 Aveva Drug Delivery Systems Recent Development
7.7 Corium International, Inc
7.7.1 Corium International, Inc Company Details
7.7.2 Corium International, Inc Business Overview
7.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
7.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.7.5 Corium International, Inc Recent Development
7.8 DURECT Corporation
7.8.1 DURECT Corporation Company Details
7.8.2 DURECT Corporation Business Overview
7.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
7.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.8.5 DURECT Corporation Recent Development
7.9 Generex Biotechnology Corporation
7.9.1 Generex Biotechnology Corporation Company Details
7.9.2 Generex Biotechnology Corporation Business Overview
7.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
7.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.9.5 Generex Biotechnology Corporation Recent Development
7.10 Inovio Pharmaceuticals, Inc.
7.10.1 Inovio Pharmaceuticals, Inc. Company Details
7.10.2 Inovio Pharmaceuticals, Inc. Business Overview
7.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
7.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.10.5 Inovio Pharmaceuticals, Inc. Recent Development
7.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
7.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
7.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
7.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
7.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
7.12 MedPharm LTD
7.12.1 MedPharm LTD Company Details
7.12.2 MedPharm LTD Business Overview
7.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
7.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.12.5 MedPharm LTD Recent Development
7.13 Mylan, Inc.
7.13.1 Mylan, Inc. Company Details
7.13.2 Mylan, Inc. Business Overview
7.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
7.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.13.5 Mylan, Inc. Recent Development
7.14 Nemaura Pharma Ltd
7.14.1 Nemaura Pharma Ltd Company Details
7.14.2 Nemaura Pharma Ltd Business Overview
7.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
7.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.14.5 Nemaura Pharma Ltd Recent Development
7.15 Nitto Denko Corporation
7.15.1 Nitto Denko Corporation Company Details
7.15.2 Nitto Denko Corporation Business Overview
7.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
7.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.15.5 Nitto Denko Corporation Recent Development
7.16 Noven Pharmaceuticals, Inc.
7.16.1 Noven Pharmaceuticals, Inc. Company Details
7.16.2 Noven Pharmaceuticals, Inc. Business Overview
7.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
7.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.16.5 Noven Pharmaceuticals, Inc. Recent Development
7.17 Pantec Biosolutions AG
7.17.1 Pantec Biosolutions AG Company Details
7.17.2 Pantec Biosolutions AG Business Overview
7.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
7.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.17.5 Pantec Biosolutions AG Recent Development
7.18 Tapemark
7.18.1 Tapemark Company Details
7.18.2 Tapemark Business Overview
7.18.3 Tapemark Transmucosal Drug Delivery Introduction
7.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.18.5 Tapemark Recent Development
7.19 tesa Labtec GmbH
7.19.1 tesa Labtec GmbH Company Details
7.19.2 tesa Labtec GmbH Business Overview
7.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
7.19.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.19.5 tesa Labtec GmbH Recent Development
7.20 TEVA Pharmaceutical Industries Ltd.
7.20.1 TEVA Pharmaceutical Industries Ltd. Company Details
7.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
7.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
7.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.20.5 TEVA Pharmaceutical Industries Ltd. Recent Development
7.21 Zosano Pharma
7.21.1 Zosano Pharma Company Details
7.21.2 Zosano Pharma Business Overview
7.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
7.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.21.5 Zosano Pharma Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
